1. Home
  2. AVNW vs TNXP Comparison

AVNW vs TNXP Comparison

Compare AVNW & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aviat Networks Inc.

AVNW

Aviat Networks Inc.

HOLD

Current Price

$17.88

Market Cap

204.6M

Sector

Technology

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$12.69

Market Cap

198.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVNW
TNXP
Founded
2006
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
204.6M
198.6M
IPO Year
2007
2008

Fundamental Metrics

Financial Performance
Metric
AVNW
TNXP
Price
$17.88
$12.69
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$34.50
N/A
AVG Volume (30 Days)
247.2K
418.4K
Earning Date
05-04-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.75
EPS
0.29
N/A
Revenue
$243,858,000.00
$13,107,000.00
Revenue This Year
$5.59
$558.11
Revenue Next Year
$7.03
$38.29
P/E Ratio
$62.17
N/A
Revenue Growth
0.56
29.85
52 Week Low
$13.92
$11.60
52 Week High
$27.02
$69.65

Technical Indicators

Market Signals
Indicator
AVNW
TNXP
Relative Strength Index (RSI) 46.25 44.73
Support Level $14.27 $12.43
Resistance Level $22.45 $15.19
Average True Range (ATR) 0.82 1.12
MACD 0.40 -0.19
Stochastic Oscillator 86.35 16.84

Price Performance

Historical Comparison
AVNW
TNXP

About AVNW Aviat Networks Inc.

Aviat Networks Inc provides wireless transport and access networking solutions designed to support telecommunications operators and private network providers situated in various countries. The company offers a range of microwave and millimeter wave radios, network management tools, and services that enable high-capacity, secure, and reliable data transport over wireless networks. Its products serve diverse clients including mobile operators, public safety organizations, utilities, government agencies, and enterprise customers. Aviat generates revenue from the sale of its networking equipment, professional services, and ongoing support contracts. Its operations cover various regions including the Americas, Europe, Asia Pacific, the Middle East, and Africa.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: